| |
| |
|
| Insider
Information: |
Blackwell Kimberly |
| Relationship: |
Chief Executive Office... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
484,145 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
484,145 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zentalis Pharmaceuticals, Llc |
ZNTL |
Chief Executive Office... |
2024-02-01 |
484,145 |
2021-06-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2024-02-01 |
4 |
D |
$11.69 |
$241,457 |
D/D |
(20,655) |
484,145 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
504,800 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2023-11-13 |
4 |
B |
$10.29 |
$51,448 |
D/D |
5,000 |
254,800 |
2.81 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
244,800 |
249,800 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2022-01-03 |
4 |
AS |
$83.74 |
$83,740 |
D/D |
(1,000) |
5,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2022-01-03 |
4 |
OE |
$47.80 |
$47,800 |
D/D |
1,000 |
6,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2021-11-01 |
4 |
AS |
$80.46 |
$80,460 |
D/D |
(1,000) |
5,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2021-11-01 |
4 |
OE |
$47.80 |
$47,800 |
D/D |
1,000 |
6,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2021-10-25 |
4 |
AS |
$77.59 |
$77,590 |
D/D |
(1,000) |
5,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2021-10-25 |
4 |
OE |
$47.80 |
$47,800 |
D/D |
1,000 |
6,000 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2021-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
